Feasibility of Breast-Conservation Therapy and Hypofractionated Radiation in the Setting of Prior Breast Augmentation.

Practical radiation oncology 2020 Vol.10(5) p. e357-e362

Tadros AB, Moo TA, Zabor EC, Gillespie EF, Khan A, McCormick B, Cahlon O, Powell SN, Allen R, Morrow M, Braunstein LZ

관련 도메인

Abstract

[PURPOSE] Cosmetic outcomes and rate of implant loss are poorly characterized among patients with breast cancer with previous breast augmentation (BA) who undergo breast-conservation therapy (BCT). Here we determine capsular contracture and implant loss frequency after BCT among patients receiving contemporary whole-breast radiation therapy (RT).

[METHODS AND MATERIALS] Patients with breast cancer with a history of BA presenting to our institution from January 2006 to January 2017 who elected for BCT were included. Seventy-one breast cancers in 70 patients with a history of BA electing for BCT were retrospectively identified. Clinicopathologic, treatment, and outcome variables were examined. Whole-breast RT included conventional and hypofractionated schedules with and without a boost. Rates of implant loss and cosmetic outcomes among patients who did and did not develop a new/worse contracture based on physician assessment were compared.

[RESULTS] In the study, 54.9% of patients received radiation using hypofractionated whole-breast tangents; 81.7% received a boost. In addition, 18 out of 71 cases (25.4%) developed a new/worse contracture after BCT with a mean follow-up of 1.9 years. Furthermore, 9 out of 71 cases (12.7%) were referred to a plastic surgeon for revisional surgery. There were no implant-loss cases. On univariate analysis, implant location, time from implant placement to diagnosis, RT type, RT boost, body mass index, and tumor size were not associated with new/worse contracture. Of 12 patients with existing contracture, only 2 developed worsening contracture. Physician assessment of cosmetic outcome after BCT was noted to be excellent or good for 87.4% of patients.

[CONCLUSIONS] BCT for breast cancer patients with prior history of BA has a low risk of implant loss. Hypofractionated RT does not adversely affect implant outcomes. Patients should be counseled regarding risk for capsular contracture, but the majority have good/excellent outcome; BA does not represent a contraindication to BCT.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 11
시술 breast augmentation 유방성형술 dict 2
합병증 capsular contracture 피막구축 dict 2
약물 [RESULTS] scispacy 1
약물 [CONCLUSIONS] BCT scispacy 1
질환 implant loss scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 implant loss frequency scispacy 1
질환 breast cancers C0006142
Malignant neoplasm of breast
scispacy 1
질환 contracture C0009917
Contracture
scispacy 1
질환 tumor C0027651
Neoplasms
scispacy 1
질환 new/worse contracture scispacy 1
질환 BCT → breast-conservation therapy scispacy 1
질환 breast cancer patients scispacy 1
기타 patients scispacy 1
기타 capsular scispacy 1

MeSH Terms

Adult; Breast Implants; Breast Neoplasms; Feasibility Studies; Humans; Mastectomy, Segmental; Middle Aged; Retrospective Studies; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문